CN114904050A - Preparation method and application of hydrogel for simulating spinal cord - Google Patents
Preparation method and application of hydrogel for simulating spinal cord Download PDFInfo
- Publication number
- CN114904050A CN114904050A CN202210769310.4A CN202210769310A CN114904050A CN 114904050 A CN114904050 A CN 114904050A CN 202210769310 A CN202210769310 A CN 202210769310A CN 114904050 A CN114904050 A CN 114904050A
- Authority
- CN
- China
- Prior art keywords
- solution
- spinal cord
- hydrogel
- deionized water
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 46
- 210000000278 spinal cord Anatomy 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 210000001178 neural stem cell Anatomy 0.000 claims abstract description 20
- 230000004069 differentiation Effects 0.000 claims abstract description 17
- 208000020431 spinal cord injury Diseases 0.000 claims abstract description 13
- 230000008439 repair process Effects 0.000 claims abstract description 12
- 210000002569 neuron Anatomy 0.000 claims abstract description 9
- 230000000638 stimulation Effects 0.000 claims abstract description 9
- 230000001737 promoting effect Effects 0.000 claims abstract description 5
- 210000003050 axon Anatomy 0.000 claims abstract description 4
- 230000012010 growth Effects 0.000 claims abstract description 4
- 230000007659 motor function Effects 0.000 claims abstract description 4
- 239000011148 porous material Substances 0.000 claims abstract description 4
- 238000011084 recovery Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 69
- 239000008367 deionised water Substances 0.000 claims description 44
- 229910021641 deionized water Inorganic materials 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
- 238000003756 stirring Methods 0.000 claims description 22
- 229920001661 Chitosan Polymers 0.000 claims description 21
- 239000007787 solid Substances 0.000 claims description 16
- 230000010355 oscillation Effects 0.000 claims description 14
- 239000011259 mixed solution Substances 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 239000002135 nanosheet Substances 0.000 claims description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 238000004108 freeze drying Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 7
- 229920002674 hyaluronan Polymers 0.000 claims description 7
- 229960003160 hyaluronic acid Drugs 0.000 claims description 7
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 6
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- DZAUWHJDUNRCTF-UHFFFAOYSA-N 3-(3,4-dihydroxyphenyl)propanoic acid Chemical compound OC(=O)CCC1=CC=C(O)C(O)=C1 DZAUWHJDUNRCTF-UHFFFAOYSA-N 0.000 claims description 4
- 241000872931 Myoporum sandwicense Species 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 4
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- IBVAQQYNSHJXBV-UHFFFAOYSA-N adipic acid dihydrazide Chemical compound NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims 1
- 230000008569 process Effects 0.000 claims 1
- 230000001172 regenerating effect Effects 0.000 claims 1
- 238000011068 loading method Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001130 astrocyte Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000013019 agitation Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000005021 gait Effects 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004248 oligodendroglia Anatomy 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/025—Other specific inorganic materials not covered by A61L27/04 - A61L27/12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/383—Nerve cells, e.g. dendritic cells, Schwann cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3878—Nerve tissue, brain, spinal cord, nerves, dura mater
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B32/00—Carbon; Compounds thereof
- C01B32/90—Carbides
- C01B32/914—Carbides of single elements
- C01B32/921—Titanium carbide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/20—Particle morphology extending in two dimensions, e.g. plate-like
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
- C08J2405/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/011—Nanostructured additives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K7/00—Use of ingredients characterised by shape
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Polymers & Plastics (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Materials Engineering (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Electrotherapy Devices (AREA)
- Prostheses (AREA)
Abstract
The invention provides a preparation method and application of hydrogel for simulating spinal cord. The hydrogels of the present invention can be prepared rapidly at room temperature. The hydrogel has the characteristics of excellent injectability, good conductivity, certain adhesiveness, mechanical strength and the like, simulates the structure and biophysical characteristics of natural spinal cord tissues, and has the characteristics of similar pore structure, modulus, conductivity and the like with the spinal cord tissues. The conductive hydrogel can effectively promote the differentiation of the neural stem cells to neurons and the growth of axons by combining with electrical stimulation after loading the neural stem cells, and has application prospects in the aspects of promoting the repair of spinal cord injury, the recovery of motor functions and the like.
Description
Technical Field
The invention relates to a preparation method of a hydrogel material for simulating natural spinal cord tissue and application of the hydrogel material in the aspect of spinal cord injury repair.
Background
Repair of spinal cord injury has been a major research point worldwide and has not made breakthrough progress for a long time. The introduction of neural stem cells at the site of injury is currently accepted as a spinal cord repair procedure. The neural stem cells which can differentiate into neurons, astrocytes and oligodendrocytes can participate in the repair of injuries at multiple levels. However, the inhibitory microenvironment inside the spinal cord is not conducive to proliferation and differentiation of transplanted neural stem cells, and the differentiation direction is unreasonably controlled, so that excessive differentiation of astrocytes which is not conducive to injury repair affects repair of spinal cord injury.
In recent years, hydrogels have received much attention in the field of biomaterials due to their versatility and excellent biocompatibility. The characteristics of adjustability and cell loading of hydrogel are utilized to simulate the biophysical characteristics of spinal cord tissues to provide a better proliferation and differentiation microenvironment for neural stem cells. But the neural stem cells are not beneficial to the differentiation in the microenvironment with over-soft or over-hard; the spinal cord tissue is more favorable for differentiation to neurons in an environment with proper hardness (0.1-1 kPa), and the modulus of the natural spinal cord tissue is 0.1-3 kPa. In addition, the bioelectrical signals in the spinal cord tissues can promote the proliferation and differentiation of endogenous and exogenous cells, and the hydrogel can imitate the high conductivity of the natural spinal cord, so that the hydrogel is very beneficial to tissue repair. Therefore, it is necessary to design an injectable conductive hydrogel simulating spinal modulus and conductance to promote the directional differentiation of neural stem cells to neurons.
The conductive hydrogel is combined with electrical stimulation to form a promising treatment mode, and can be used for promoting the directional differentiation of the neural stem cells to the neurons and promoting the growth of the axons. Solves the problems of uncontrollable differentiation and excessive differentiation to astrocytes of the conventional neural stem cells. Therefore, the injectable conductive hydrogel loaded neural stem cells simulating the modulus and the conductivity of the spinal cord tissue has great potential in the spinal cord injury repair combined with an electrical stimulation treatment method.
Disclosure of Invention
The invention aims to provide a preparation method of a hydrogel material for simulating natural spinal cord tissue and application of the hydrogel material in spinal cord injury repair.
The method comprises the steps of firstly preparing modified chitosan CHIC, then preparing HA-ALD, and then preparing MXene nanosheets by an etching method. MXene nanosheets are mixed into an HA-ALD solution to react with a CHIC solution doped with a certain amount of ADH according to a certain proportion, and the injectable conductive hydrogel simulating the tissue structure, the modulus and the conductivity of a spinal cord can be obtained.
1) Firstly, chitosan (CHIC) modified by catechol group is prepared. Dissolving 0.5-0.8 g of chitosan in deionized water, adjusting the pH value to 5.0-6.0 by HCl, and dispersing for 20-30 min by using ultrasonic oscillation to finally form a 1.0 wt% chitosan solution. And then, dissolving 255-455 mg of dihydrocaffeic acid HCA in 5.0-8.0 mL of deionized water, fully stirring and dissolving, and then adding into the chitosan liquid. Dissolving 240-300 mg of 1-ethyl- (3-dimethylaminopropyl) carbodiimide EDC and 150-200 mg of n-hydroxy thiosuccinimide NHS in 50.0mL of a mixed solution of ethanol and deionized water in a ratio of 1: 1-1: 2, and keeping the pH value within a range of 6-7. And slowly dripping the chitosan/HCA mixed solution into the mixture, reacting in an environment of 20-25 ℃, sealing and violently stirring for 10-12 h, keeping the pH value at 5.0-6.0, and then placing in an oscillator for fast shaking reaction for 10-15 min. Dialyzing the solution in acidified deionized water for 2-3 days, dialyzing in deionized water for half a day, and freeze-drying in a freeze-dryer to obtain a yellow solid, namely preparing the catechol group-modified chitosan CHIC.
2) Preparation of aldehyde radicalHyaluronic acid HA-ALD. Dissolving 2.0-3.0 g of hyaluronic acid HA in 200-300 mL of deionized water, and sealing and rapidly stirring for 24-28 h at 20-25 ℃ until the hyaluronic acid HA is completely dissolved. 1.0-1.5 g NaIO 4 Adding the HA solution into the solution, stirring the solution for 4 to 7 hours in a dark place, adding 1.5 to 2.3mL of ethylene glycol, stirring the solution for 1 to 2 hours, and then carrying out ultrasonic oscillation reaction for 10 to 20 min. Putting the solution into a dialysis bag, dialyzing with deionized water for 3-4 days, and keeping the pH of the solution within a range of 7-8. And (3) putting the reactant into a freeze dryer for drying, and finally obtaining a white solid, namely the aldehyde hyaluronic acid HA-ALD.
3) Preparing MXene nano-sheets. Adding 1-4 g of LiF into 20-80 mL of hydrochloric acid, and stirring for 5-10 min. Then adding 1-4 g of Ti 3 AlC 2 Slowly adding the solution and stirring for 24-26 h at 35-40 ℃. Washing the acidic suspension with deionized water, and centrifuging at 3500-4500 rpm for 5-8 min until the pH value of the supernatant reaches 6-7. And then collecting the deposit, adding deionized water into the deposit, introducing Ar into the dispersion liquid for 10-20 min, and dispersing for 1-1.5 h by using ultrasonic oscillation while ensuring the temperature to be within 30 ℃. And finally, centrifuging at the rotating speed of 4500-5000 for 10-15 minutes, and freeze-drying at the temperature of-50 to-30 ℃ for 2-3 days to obtain black solid powder MXene nanosheets.
4) Preparing a 4-6 wt% solution of the CHIC solid by using deionized water, and adding 1.0-2.0 wt% of adipic dihydrazide ADH to prepare a light yellow solution A. And then adding the HA-ALD into deionized water to prepare a 4-6 wt% solution, adding 0.1-0.15% wtMXene nanosheet powder, and performing ultrasonic oscillation for 10-15 min to obtain a black solution B. And mixing the solution A and the solution B according to the volume ratio of 1: 2-3: 1, and quickly mixing and reacting for 10-60 seconds by using an oscillator. The injectable conductive hydrogel which simulates the structure, modulus and conductivity of spinal cord tissue can be obtained.
The invention has the following advantages: 1. the synthesized hydrogel has the advantages of good main raw material and biocompatibility, and is beneficial to commercialization of products; 2. the conductive hydrogel simulates the structure and biophysical characteristics of natural spinal cord tissue, has the characteristics of similar pore structure, modulus, conductivity and the like with the spinal cord tissue, and is beneficial to promoting the directional differentiation of neural stem cells; 4, the hydrogel has the characteristics of injectability, adhesiveness, conductivity, mechanical strength and the like, and can close irregular defects after spinal cord injury; 5. the hydrogel has a hemostatic function, and can effectively avoid inflammatory reaction caused by bleeding at the spinal cord injury part; 6. the conductive hydrogel can effectively promote the differentiation of the neural stem cells to neurons and the growth of axons by combining with electrical stimulation after loading the neural stem cells; 7. when the injectable conductive hydrogel loaded with the neural stem cells is injected into the spinal cord injury part and is assisted by electrical stimulation, the spinal cord injury repair and motor function recovery can be effectively promoted.
Drawings
FIG. 1: phase change diagram of hydrogel prepared for example 1. As can be seen from the reagent bottle inclination experiment, the injectable conductive hydrogel is formed after the solution A and the solution B are mixed into a black solution for ten seconds.
FIG. 2: is an electron micrograph of the hydrogel prepared in example 1. As can be seen, the conductive hydrogel has a three-dimensional network pore structure similar to the spinal cord.
FIG. 3: a graph of the rheological data for the hydrogel prepared in example 1. As can be seen, the modulus of the hydrogel is about 950kPa, is close to the modulus of the natural spinal cord tissue, and is favorable for the differentiation of neural stem cells to neurons.
FIG. 4: after the hydrogel prepared in example 1 is loaded with neural stem cells, the differentiation of the neural stem cells to neurons can be effectively promoted by combining with electrical stimulation.
FIG. 5: the injectable conductive hydrogel loaded with the neural stem cells prepared in example 1 is injected into a rat spinal cord total-section model and then is combined with electrical stimulation treatment to obtain a rat gait condition. It can be seen from the figure that the motor function of the group of rats was significantly restored as observed by gait after combination with electrical stimulation.
Detailed Description
Example 1
(1)0.5g of chitosan was dissolved in deionized water, the pH was adjusted to 5.5 by HCl, and then dispersed for 20min using ultrasonic agitation to form a 1.0% wt chitosan solution. Then 300mg of HCA was dissolved in 5.0mL of deionized water, and added to the chitosan solution after fully stirred and dissolved. Dissolving 240mg of EDC and 150mg of NHS in 50.0mL of mixed solution of ethanol and deionized water in a ratio of 1:1, and keeping the pH value between 6 and 7. Then slowly dropping the chitosan/HCA mixed solution into the mixed solution, sealing and stirring vigorously for 10h in an environment with the temperature of 20 ℃, keeping the pH value at 5.5, and then placing the mixed solution in an oscillator to shake rapidly for 10 min. Dialyzing the solution in acidified deionized water for 2 days, then dialyzing in deionized water for half a day, and freeze-drying in a freeze dryer to obtain yellow solid.
(2) 2.0g HA was dissolved in 200mL deionized water and sealed under rapid stirring at 20 ℃ for 24h to dissolve completely. 1.0g NaIO 4 Adding the HA solution into the solution, stirring the solution for 5 hours in a dark place, adding 1.5mL of glycol, stirring the solution for 1.5 hours, and carrying out ultrasonic oscillation reaction for 15 min. Putting the solution into a dialysis bag, dialyzing with deionized water for 3 days, and keeping the pH of the solution between 7 and 8. The reaction mass is put into a freeze dryer for freeze drying to finally obtain white solid.
(3) 1g of LiF was added to 20mL of hydrochloric acid and stirred for 5 min. 1g of Ti 3 AlC 2 The above solution was slowly added and stirred at 35 ℃ for 26h to give a black suspension. The acidic suspension was then washed with deionized water and centrifuged at 4500 rpm for 5min until the supernatant reached pH 6.0. And then collecting the deposit, adding deionized water into the deposit, introducing Ar into the dispersion liquid for 10min, dispersing for 1h by using ultrasonic oscillation, and adding and ensuring the temperature to be within 30 ℃. And finally, centrifuging at the rotating speed of 5000 for 10min, and freeze-drying at the temperature of 50 ℃ below zero for 3 days to obtain fluffy black powder A of the MXene nanosheets.
(4) Preparing a 5 wt% solution of the CHIC solid by using deionized water, and adding 1.0 wt% ADH to prepare a light yellow solution A; and then adding the HA-ALD solid into deionized water to prepare a 5 wt% solution, adding 0.1% wtMXene nanosheet powder, and performing ultrasonic oscillation for 10min to prepare a black solution B. Mixing the solution A and the solution B according to the volume ratio of 1:1, mixing and reacting for 10 seconds by a vibrator to finally obtain the injectable conductive hydrogel simulating spinal cord tissue.
Example 2
(1)0.8g of chitosan was dissolved in deionized water, the pH was adjusted to 5 by HCl, and then dispersed for 25min using ultrasonic agitation to form a 1.0% wt chitosan solution. Then, 420mg of HCA was dissolved in 6.0mL of deionized water, and the solution was added to the chitosan solution after being sufficiently stirred and dissolved. Dissolving 280mg of EDC and 190mg of NHS in 50.0mL of mixed solution of ethanol and deionized water in a ratio of 1:2, and keeping the pH value between 6 and 7. Then slowly dropping the chitosan/HCA mixed solution into the mixed solution, sealing and stirring vigorously for 12h in an environment with the temperature of 25 ℃, keeping the pH value at 5, and then placing the mixed solution in an oscillator to shake rapidly for 15 min. Dialyzing the solution in acidified deionized water for 3 days, then dialyzing in deionized water for half a day, and freeze-drying in a freeze dryer to obtain yellow solid.
(2) 3.0g HA was dissolved in 300mL deionized water and stirred under sealed rapid stirring at 25 ℃ for 24h to dissolve completely. 1.2g NaIO 4 Adding the HA solution into the solution, stirring the solution for 4 hours in a dark place, adding 2mL of glycol, stirring the solution for 2 hours, and carrying out ultrasonic oscillation reaction for 20 min. Putting the solution into a dialysis bag, dialyzing with deionized water for 3 days, and keeping the pH of the solution between 7 and 8. The reaction mass is put into a freeze dryer for freeze drying to finally obtain white solid.
(3) 1g of LiF was added to 20mL of hydrochloric acid and stirred for 5 min. Mixing 1g of Ti 3 AlC 2 The solution was slowly added and stirred at 40 ℃ for 24h to give a black suspension. The acidic suspension was then washed with deionized water and centrifuged at 3500 rpm for 8min until the supernatant reached a pH of 6.0. Then collecting the deposit, adding deionized water into the deposit, introducing Ar into the dispersion liquid for 20min, and dispersing for 1.5h by using ultrasonic oscillation while ensuring the temperature to be within 30 ℃. And finally, centrifuging at the rotating speed of 4500 for 10min, and freeze-drying at-50 ℃ for 3 days to obtain fluffy black powder A of the MXene nanosheet.
(4) Preparing a 6 wt% solution of the CHIC solid by using deionized water, and adding 1.5 wt% of adipic dihydrazide ADH to prepare a light yellow solution A. And then adding a proper amount of deionized water into the HA-ALD solid to prepare 6 wt% of solution, adding 0.12% of wtMXene nanosheet powder, and performing ultrasonic oscillation for 15min to prepare a black solution B. Mixing the solution A and the solution B according to a volume ratio of 2: 3, mixing, and rapidly mixing and reacting for 60 seconds by using an oscillator to finally obtain the injectable conductive hydrogel simulating spinal cord tissue.
Claims (4)
1. A preparation method of hydrogel simulating spinal cord is characterized in that: the method comprises the following specific steps:
1) firstly, preparing catechol group modified chitosan (CHIC); dissolving 0.5-0.8 g of chitosan in deionized water, adjusting the pH to 5.0-6.0 by HCl, and then dispersing for 20-30 min by using ultrasonic oscillation to finally form a 1.0 wt% chitosan solution; then, dissolving 255-455 mg of dihydrocaffeic acid HCA in 5.0-8.0 mL of deionized water, fully stirring and dissolving, and then adding into chitosan liquid; dissolving 240-300 mg of 1-ethyl- (3-dimethylaminopropyl) carbodiimide EDC and 150-200 mg of n-hydroxy thiosuccinimide NHS in 50.0mL of a mixed solution of ethanol and deionized water in a ratio of 1: 1-1: 2, and keeping the pH value within a range of 6-7; slowly dripping the chitosan/HCA mixed solution into the mixed solution, reacting in an environment of 20-25 ℃, sealing and violently stirring for 10-12 h, keeping the pH value at 5.0-6.0, and then placing in an oscillator for fast shaking reaction for 10-15 min; dialyzing the solution in acidified deionized water for 2-3 days, dialyzing in deionized water for half a day, and freeze-drying in a freeze dryer to obtain a yellow solid, namely preparing the catechol group-modified chitosan CHIC;
2) preparing aldehyde hyaluronic acid HA-ALD; dissolving 2.0-3.0 g of hyaluronic acid HA in 200-300 mL of deionized water, and sealing and rapidly stirring for 24-28 h in an environment at 20-25 ℃ until the hyaluronic acid HA is completely dissolved; 1.0-1.5 g NaIO 4 Adding the HA solution into the solution, stirring the solution for 4 to 7 hours in a dark place, adding 1.5 to 2.3mL of ethylene glycol, stirring the solution for 1 to 2 hours, and then carrying out ultrasonic oscillation reaction for 10 to 20 min; putting the solution into a dialysis bag, dialyzing with deionized water for 3-4 days, and keeping the pH of the solution within a range of 7-8; putting the reactant into a freeze dryer for drying to finally obtain a white solid of aldehyde hyaluronic acid HA-ALD;
3) preparing MXene nanosheets; adding 1-4 g of LiF into 20-80 mL of hydrochloric acid, and stirring for 5-10 min; then adding 1-4 g of Ti 3 AlC 2 Slowly adding the solution and stirring for 24-26 h at 35-40 ℃; washing the acidic suspension with deionized water, and centrifuging at 3500-4500 rpm for 5-8 min until the pH value of the supernatant reaches 6-7; then collecting the deposit, adding deionized water into the deposit, introducing Ar into the dispersion liquid for 10-20 min, and dispersing for 1-1.5 h by using ultrasonic oscillation while ensuring the temperature to be within 30 ℃; finally, centrifuging at the rotating speed of 4500-5000 for 1Freeze-drying for 0-15 minutes at-50 to-30 ℃ for 2-3 days to obtain black solid powder as MXene nanosheets;
4) preparing a CHIC solid into a 4-6 wt% solution by using deionized water, and adding 1.0-2.0 wt% of adipic dihydrazide ADH into the solution to prepare a light yellow solution A; adding HA-ALD into deionized water to prepare a 4-6 wt% solution, adding 0.1-0.15% wtMXene nanosheet powder, and performing ultrasonic oscillation for 10-15 min to obtain a black solution B; mixing the solution A and the solution B according to the volume ratio of 1: 2-3: 1, and quickly mixing and reacting for 10-60 seconds by using an oscillator; the injectable conductive hydrogel which simulates the structure, modulus and conductivity of spinal cord tissue can be obtained.
2. The hydrogel prepared by the method for preparing the hydrogel simulating the spinal cord according to claim 1, wherein the method comprises the following steps: the hydrogel has the properties of a three-dimensional network porous structure, excellent injectability, good conductivity, certain adhesion, mechanical strength and the like, simulates the structure and biophysical characteristics of natural spinal cord tissues, and has the characteristics of similar pore structure, modulus, conductivity and the like as the spinal cord tissues.
3. The hydrogel prepared by the method for preparing the hydrogel simulating the spinal cord according to claim 1, wherein the method comprises the following steps: the hydrogel can effectively promote the differentiation of the neural stem cells to the neurons and the growth of the axons by combining with the electrical stimulation, and can be applied as an auxiliary material for repairing spinal cord injuries and regenerating tissues.
4. The hydrogel prepared by the method for preparing the hydrogel simulating the spinal cord according to claim 1, wherein the method comprises the following steps: the hydrogel has the characteristic of simulating spinal cord, can be used as an injectable and conductive filling material in the process of spinal cord injury repair, and has application prospects in the aspects of promoting spinal cord injury repair, motor function recovery and the like.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210769310.4A CN114904050A (en) | 2022-06-30 | 2022-06-30 | Preparation method and application of hydrogel for simulating spinal cord |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210769310.4A CN114904050A (en) | 2022-06-30 | 2022-06-30 | Preparation method and application of hydrogel for simulating spinal cord |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114904050A true CN114904050A (en) | 2022-08-16 |
Family
ID=82771723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210769310.4A Pending CN114904050A (en) | 2022-06-30 | 2022-06-30 | Preparation method and application of hydrogel for simulating spinal cord |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114904050A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108310471A (en) * | 2018-01-04 | 2018-07-24 | 重庆大学 | A kind of good enzyme response antibacterial titanium preparation method of biocompatibility |
WO2019116135A1 (en) * | 2017-12-12 | 2019-06-20 | King Abdullah University Of Science And Technology | Multimodal strain sensor and method |
CN112011067A (en) * | 2020-08-19 | 2020-12-01 | 华东师范大学 | Degradable, self-repairing and self-adhering conductive hydrogel and preparation method thereof |
CN113292674A (en) * | 2021-05-28 | 2021-08-24 | 吉林大学 | Preparation method and application of novel adhesion and high-conductivity hydrogel |
CN113425899A (en) * | 2021-06-18 | 2021-09-24 | 华中科技大学 | Conductive degradable multifunctional tissue engineering scaffold and preparation method thereof |
CN113512207A (en) * | 2021-05-28 | 2021-10-19 | 吉林大学 | Preparation method and application of oriented conductive low-temperature-resistant hydrogel |
CN113521390A (en) * | 2020-04-21 | 2021-10-22 | 中国科学院苏州纳米技术与纳米仿生研究所 | 3D printing biological ink for spinal cord injury repair, preparation method and application |
-
2022
- 2022-06-30 CN CN202210769310.4A patent/CN114904050A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019116135A1 (en) * | 2017-12-12 | 2019-06-20 | King Abdullah University Of Science And Technology | Multimodal strain sensor and method |
CN108310471A (en) * | 2018-01-04 | 2018-07-24 | 重庆大学 | A kind of good enzyme response antibacterial titanium preparation method of biocompatibility |
CN113521390A (en) * | 2020-04-21 | 2021-10-22 | 中国科学院苏州纳米技术与纳米仿生研究所 | 3D printing biological ink for spinal cord injury repair, preparation method and application |
CN112011067A (en) * | 2020-08-19 | 2020-12-01 | 华东师范大学 | Degradable, self-repairing and self-adhering conductive hydrogel and preparation method thereof |
CN113292674A (en) * | 2021-05-28 | 2021-08-24 | 吉林大学 | Preparation method and application of novel adhesion and high-conductivity hydrogel |
CN113512207A (en) * | 2021-05-28 | 2021-10-19 | 吉林大学 | Preparation method and application of oriented conductive low-temperature-resistant hydrogel |
CN113425899A (en) * | 2021-06-18 | 2021-09-24 | 华中科技大学 | Conductive degradable multifunctional tissue engineering scaffold and preparation method thereof |
Non-Patent Citations (7)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101428145B1 (en) | Water-insoluble gel composition and manufacturing method of the same | |
CN102942660B (en) | Natural biological crosslinking nanocomposite three-dimensional gel bracket and preparation method | |
CN110885455B (en) | Preparation and application of active oxygen response hydrogel | |
CN110522948B (en) | Injectable hydrogel and preparation method and application thereof | |
CN109734851B (en) | Temperature-sensitive polymer, synthesis method thereof and temperature-sensitive injectable hydrogel | |
CN110172163B (en) | Method for preparing silk fibroin-tyramine modified hyaluronic acid hydrogel material based on physical-chemical double crosslinking | |
CN111588913A (en) | Self-crosslinking hyaluronic acid and hydrogel injection of composite collagen thereof and application of hydrogel injection | |
CN107137765A (en) | Polypyrrole biological conductive hydrogel and preparation method and application thereof | |
CN111905152B (en) | Silicon-based bioactive glass composite hydrogel with self-healing characteristic, preparation method thereof and application thereof in myocardial repair | |
CN110498936A (en) | A kind of preparation method of Sodium Hyaluronate/sodium alginate injection-type composite hydrogel | |
CN111825859A (en) | Bionic electronic skin medical stent material with self-repairing function and preparation method thereof | |
CN101824160A (en) | Preparation method of chitosan/polyvinyl alcohol/polylactic acid blended porous membrane | |
CN110964215A (en) | Preparation method of L-polylactic acid and cross-linked hyaluronic acid composite gel for injection and obtained product | |
CN112980010B (en) | Injectable conductive gel and preparation method and application thereof | |
CN113150561B (en) | Collagen-based biological ink for 3D biological printing and preparation method and application thereof | |
CN110305253A (en) | Aoxidize homogeneous bracket of alginate/polyacrylamide interpenetrating networks medical composite type and preparation method thereof | |
CN110698866A (en) | Ultrasonic-mediated silk fibroin composite collagen hydrogel and preparation method thereof | |
CN112043865A (en) | Strontium hydroxyapatite and sodium alginate composite injectable hydrogel with adhesion and preparation method and application thereof | |
CN110180023B (en) | Preparation method of high-strength biomass tissue engineering scaffold material | |
CN115429935A (en) | Injectable cross-linked chondroitin sulfate hydrogel and preparation method thereof | |
CN104707179B (en) | Oil-soluble/water-soluble organic-inorganic three-phase porous micro-nanometer composite bone repair material | |
CN108653818A (en) | A kind of reversible collagen stimulation filler and preparation method thereof | |
CN105801870B (en) | The preparation method and products obtained therefrom of a kind of poly sialic acid-hyaluronic acid plural gel and application | |
CN114904050A (en) | Preparation method and application of hydrogel for simulating spinal cord | |
CN106730020A (en) | A kind of strontium carbonate modified fibroin composite and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220816 |
|
RJ01 | Rejection of invention patent application after publication |